Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Obagi Medical Products, Inc.
(NQ:
OMPI
)
23.98
USD
UNCHANGED
Last Price
/ Updated:
4:00 PM EDT, Apr 25, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
23.98 (59664)
Ask (Size)
23.99 (1800)
Prev. Close
23.98
Today's Range
23.98 - 23.98
52wk Range
10.70 - 25.60
Shares Outstanding
17,434,138
Dividend Yield
N/A
Top News
More News
62.9% Return Seen to Date on SmarTrend Obagi Medical Products Call (OMPI)
May 07, 2013
from
Comtex SmarTrend® News Briefs
62.9% Return Seen to Date on SmarTrend Obagi Medical Products Call (OMPI)
April 30, 2013
from
Comtex SmarTrend® News Briefs
More News
Read More
Merger of Dugmakers Valeant, Actavis on Hold: Source
April 28, 2013
category
Places/North America
,
Places/North America/United States/New York
,
Biotechnology
, and 17 more.
from
CNBC.com News
Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.
April 25, 2013
from
PR Newswire
Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc.
April 24, 2013
from
PR Newswire
63.0% Return Seen to Date on SmarTrend Obagi Medical Products Call (OMPI)
April 23, 2013
from
Comtex SmarTrend® News Briefs
Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
April 23, 2013
from
PR Newswire
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
April 22, 2013
from
PR Newswire
Obagi Medical Products Up 62.8% Since SmarTrend Uptrend Call (OMPI)
April 15, 2013
from
Comtex SmarTrend® News Briefs
Free Research Reports on ANAC, GE, OMPI and PCYC Issued by the Paragon Report
April 09, 2013
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.